Families failed by Covid vaccines tell inquiry of their pain


The UK Covid Inquiry has heard from groups representing victims of Covid vaccines who have been left unsupported throughout the pandemic. Kate Scott, a member of the group Vaccine Injured and Bereaved UK (VIBUK), told the inquiry that the group “felt like they were almost being pushed into the shadows during the pandemic”, while a Scottish victims’ group raised concerns that speed had been prioritised over safety during the vaccine rollout. The inquiry will focus on issues relating to the development and implementation of Covid-19 vaccines.

Scott’s husband Jamie suffered a rare and life-threatening side effect called Vaccine-Induced Immune Thrombosis and Thrombocytopenia (VITT) and spent five weeks in a coma after receiving the vaccine. Although he survived, he has been left blind and with significant brain damage. Scott has received compensation of £120,000 from the government’s Vaccine Damage Payment Scheme, but his wife has stated that this is not a fair or adequate amount, calling the scheme “inadequate and inefficient”.

Jean Rossiter, mother of music teacher Peter Rossiter, who died after contracting Covid-19 in August 2021, also spoke at the inquiry. Rossiter only received his first vaccine in May 2021 and became seriously ill with the virus later that year. His mother has criticised delays in vaccine distribution and poor communication of guidance for the public, as well as the prioritisation of certain groups over others.

Finally, the Scottish Vaccine Injury Group (SVIG), which represents 750 people, has expressed concerns about the speed of the vaccine rollout and the government’s vaccine damage payment scheme. Ruth O’Rafferty, from the SVIG, has called the experience of applying to the scheme “traumatic”, and expressed concerns that many members have suffered neurological damage that makes it difficult for them to fill out forms. The inquiry will hear evidence on this issue over the next three weeks

Read the full article from The BBC here: Read More